Chapter/Section Purchase

1 Introduction to Research & Analysis Reports
1.1 Human Microbiome Therapeutic Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Human Microbiome Therapeutic Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Human Microbiome Therapeutic Drugs Overall Market Size
2.1 Global Human Microbiome Therapeutic Drugs Market Size: 2021 VS 2028
2.2 Global Human Microbiome Therapeutic Drugs Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Human Microbiome Therapeutic Drugs Players in Global Market
3.2 Top Global Human Microbiome Therapeutic Drugs Companies Ranked by Revenue
3.3 Global Human Microbiome Therapeutic Drugs Revenue by Companies
3.4 Top 3 and Top 5 Human Microbiome Therapeutic Drugs Companies in Global Market, by Revenue in 2021
3.5 Global Companies Human Microbiome Therapeutic Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Human Microbiome Therapeutic Drugs Players in Global Market
3.6.1 List of Global Tier 1 Human Microbiome Therapeutic Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Human Microbiome Therapeutic Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Human Microbiome Therapeutic Drugs Market Size Markets, 2021 & 2028
4.1.2 FMT
4.1.3 Microbiome Drugs
4.1.4 Others
4.2 By Type - Global Human Microbiome Therapeutic Drugs Revenue & Forecasts
4.2.1 By Type - Global Human Microbiome Therapeutic Drugs Revenue, 2017-2022
4.2.2 By Type - Global Human Microbiome Therapeutic Drugs Revenue, 2023-2028
4.2.3 By Type - Global Human Microbiome Therapeutic Drugs Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Human Microbiome Therapeutic Drugs Market Size, 2021 & 2028
5.1.2 Stomach
5.1.3 Oral
5.1.4 Respiratory Tract
5.1.5 Others
5.2 By Application - Global Human Microbiome Therapeutic Drugs Revenue & Forecasts
5.2.1 By Application - Global Human Microbiome Therapeutic Drugs Revenue, 2017-2022
5.2.2 By Application - Global Human Microbiome Therapeutic Drugs Revenue, 2023-2028
5.2.3 By Application - Global Human Microbiome Therapeutic Drugs Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Human Microbiome Therapeutic Drugs Market Size, 2021 & 2028
6.2 By Region - Global Human Microbiome Therapeutic Drugs Revenue & Forecasts
6.2.1 By Region - Global Human Microbiome Therapeutic Drugs Revenue, 2017-2022
6.2.2 By Region - Global Human Microbiome Therapeutic Drugs Revenue, 2023-2028
6.2.3 By Region - Global Human Microbiome Therapeutic Drugs Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Human Microbiome Therapeutic Drugs Revenue, 2017-2028
6.3.2 US Human Microbiome Therapeutic Drugs Market Size, 2017-2028
6.3.3 Canada Human Microbiome Therapeutic Drugs Market Size, 2017-2028
6.3.4 Mexico Human Microbiome Therapeutic Drugs Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Human Microbiome Therapeutic Drugs Revenue, 2017-2028
6.4.2 Germany Human Microbiome Therapeutic Drugs Market Size, 2017-2028
6.4.3 France Human Microbiome Therapeutic Drugs Market Size, 2017-2028
6.4.4 U.K. Human Microbiome Therapeutic Drugs Market Size, 2017-2028
6.4.5 Italy Human Microbiome Therapeutic Drugs Market Size, 2017-2028
6.4.6 Russia Human Microbiome Therapeutic Drugs Market Size, 2017-2028
6.4.7 Nordic Countries Human Microbiome Therapeutic Drugs Market Size, 2017-2028
6.4.8 Benelux Human Microbiome Therapeutic Drugs Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Human Microbiome Therapeutic Drugs Revenue, 2017-2028
6.5.2 China Human Microbiome Therapeutic Drugs Market Size, 2017-2028
6.5.3 Japan Human Microbiome Therapeutic Drugs Market Size, 2017-2028
6.5.4 South Korea Human Microbiome Therapeutic Drugs Market Size, 2017-2028
6.5.5 Southeast Asia Human Microbiome Therapeutic Drugs Market Size, 2017-2028
6.5.6 India Human Microbiome Therapeutic Drugs Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Human Microbiome Therapeutic Drugs Revenue, 2017-2028
6.6.2 Brazil Human Microbiome Therapeutic Drugs Market Size, 2017-2028
6.6.3 Argentina Human Microbiome Therapeutic Drugs Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Human Microbiome Therapeutic Drugs Revenue, 2017-2028
6.7.2 Turkey Human Microbiome Therapeutic Drugs Market Size, 2017-2028
6.7.3 Israel Human Microbiome Therapeutic Drugs Market Size, 2017-2028
6.7.4 Saudi Arabia Human Microbiome Therapeutic Drugs Market Size, 2017-2028
6.7.5 UAE Human Microbiome Therapeutic Drugs Market Size, 2017-2028
7 Players Profiles
7.1 Rebiotix
7.1.1 Rebiotix Corporate Summary
7.1.2 Rebiotix Business Overview
7.1.3 Rebiotix Human Microbiome Therapeutic Drugs Major Product Offerings
7.1.4 Rebiotix Human Microbiome Therapeutic Drugs Revenue in Global Market (2017-2022)
7.1.5 Rebiotix Key News
7.2 Seres Therapeutics
7.2.1 Seres Therapeutics Corporate Summary
7.2.2 Seres Therapeutics Business Overview
7.2.3 Seres Therapeutics Human Microbiome Therapeutic Drugs Major Product Offerings
7.2.4 Seres Therapeutics Human Microbiome Therapeutic Drugs Revenue in Global Market (2017-2022)
7.2.5 Seres Therapeutics Key News
7.3 Vedanta Biosciences
7.3.1 Vedanta Biosciences Corporate Summary
7.3.2 Vedanta Biosciences Business Overview
7.3.3 Vedanta Biosciences Human Microbiome Therapeutic Drugs Major Product Offerings
7.3.4 Vedanta Biosciences Human Microbiome Therapeutic Drugs Revenue in Global Market (2017-2022)
7.3.5 Vedanta Biosciences Key News
7.4 Bristol-Myers Squibb
7.4.1 Bristol-Myers Squibb Corporate Summary
7.4.2 Bristol-Myers Squibb Business Overview
7.4.3 Bristol-Myers Squibb Human Microbiome Therapeutic Drugs Major Product Offerings
7.4.4 Bristol-Myers Squibb Human Microbiome Therapeutic Drugs Revenue in Global Market (2017-2022)
7.4.5 Bristol-Myers Squibb Key News
7.5 Johnson and Johnson
7.5.1 Johnson and Johnson Corporate Summary
7.5.2 Johnson and Johnson Business Overview
7.5.3 Johnson and Johnson Human Microbiome Therapeutic Drugs Major Product Offerings
7.5.4 Johnson and Johnson Human Microbiome Therapeutic Drugs Revenue in Global Market (2017-2022)
7.5.5 Johnson and Johnson Key News
7.6 Takeda
7.6.1 Takeda Corporate Summary
7.6.2 Takeda Business Overview
7.6.3 Takeda Human Microbiome Therapeutic Drugs Major Product Offerings
7.6.4 Takeda Human Microbiome Therapeutic Drugs Revenue in Global Market (2017-2022)
7.6.5 Takeda Key News
7.7 ENTEROME Bioscience
7.7.1 ENTEROME Bioscience Corporate Summary
7.7.2 ENTEROME Bioscience Business Overview
7.7.3 ENTEROME Bioscience Human Microbiome Therapeutic Drugs Major Product Offerings
7.7.4 ENTEROME Bioscience Human Microbiome Therapeutic Drugs Revenue in Global Market (2017-2022)
7.7.5 ENTEROME Bioscience Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer